A new report titled “Veterinary Biomarkers Market – Forecast to 2032” by Eternal Market, the global veterinary biomarkers industry is projected to grow at a compound annual growth rate (CAGR) of 12.4% from 2023 to 2032, reaching a value of USD 2.6 billion by the end of the forecast period.
Global veterinary biomarkers industry outlook
Veterinary biomarkers are measurable indicators found in animal bodies that provide crucial insights into physiological and pathological processes. These molecules, which can include proteins, genes, hormones, and metabolites, are used to diagnose diseases, monitor treatment effectiveness, and predict health outcomes in animals. Veterinary biomarkers play a pivotal role in enhancing animal healthcare by enabling early detection and personalized treatment approaches. These biomarkers find applications across various domains, such as infectious diseases, cancer, metabolic disorders, and cardiovascular conditions, aiding veterinarians in making informed decisions about animal health management.
The applications of veterinary biomarkers are diverse, spanning from clinical diagnostics to research studies. In clinical settings, veterinarians utilize biomarkers to identify diseases at an early stage, enabling timely interventions and improving the prognosis for animals. Veterinary researchers rely on biomarkers to study disease mechanisms, assess the safety of new treatments, and develop innovative therapies. Additionally, biomarker-based approaches contribute to the field of One Health, facilitating the understanding of zoonotic diseases that can affect both animals and humans. End users of veterinary biomarkers include veterinary clinics, animal hospitals, research institutions, pharmaceutical companies, and livestock industries. These stakeholders harness biomarker information to enhance animal well-being, advance veterinary medicine, and foster sustainable agricultural practices, ultimately benefiting both animal health and human health through interconnected pathways.
Global veterinary biomarkers industry forces
Advances in diagnostics has been a significant driver for the global veterinary biomarkers market.
Advances in diagnostics have revolutionized the field of veterinary medicine, fundamentally changing how diseases are detected, diagnosed, and managed in animals. These advancements primarily stem from rapid developments in molecular biology, genomics, proteomics, and imaging technologies. In the past, diagnosing certain diseases in animals was often challenging due to the limitations of traditional methods. However, with the advent of advanced diagnostic tools, veterinarians now have the ability to identify specific biomarkers, genetic mutations, and molecular patterns associated with various conditions.
Molecular techniques, such as polymerase chain reaction (PCR) and next-generation sequencing (NGS), enable the rapid and accurate identification of pathogens responsible for infectious diseases. These techniques provide insights into the genetic makeup of microorganisms, facilitating timely diagnosis and targeted treatment strategies. Additionally, advancements in proteomics have allowed for the identification and quantification of proteins present in bodily fluids, tissues, and cells. This information aids in diagnosing diseases like cancer and monitoring treatment responses, as changes in protein profiles can indicate disease progression or therapeutic effectiveness.
Moreover, imaging technologies like magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET) have become indispensable in veterinary diagnostics. These non-invasive methods provide detailed anatomical and functional information, allowing veterinarians to visualize internal structures and identify abnormalities. As a result, early detection of conditions such as musculoskeletal disorders, neurological issues, and tumors has become more precise and efficient.
In summary, advances in diagnostics have ushered in a new era of precision and effectiveness in veterinary medicine. The integration of molecular techniques, proteomics, and sophisticated imaging technologies has expanded the diagnostic toolkit available to veterinarians, enabling them to accurately diagnose diseases, tailor treatment plans, and improve the overall health and well-being of animals.
Growing emphasis on early detection and prevention has been a significant driver for the global veterinary biomarkers market
Early detection and prevention represent pivotal strategies in veterinary medicine aimed at identifying diseases at their nascent stages and implementing interventions to mitigate their impact. By identifying biomarkers, subtle physiological changes, or genetic predispositions associated with specific conditions, veterinarians can intervene proactively before symptoms become pronounced. This approach not only enhances the prognosis and treatment outcomes for animals but also minimizes the potential for disease progression and related complications. Through regular screenings, diagnostic tests, and surveillance programs, veterinary professionals can identify risk factors and initiate preventive measures, contributing to improved animal health, reduced treatment costs, and a greater focus on promoting overall well-being in both companion animals and livestock populations.
Trends in the industry
Increasing use of artificial intelligence (AI) and machine learning (ML) in veterinary biomarker research: AI and ML are being used to identify new biomarkers and to develop better ways to analyze biomarker data. This is helping to accelerate the development of new and improved veterinary biomarker-based diagnostic tests and treatments.
Growing adoption of veterinary biomarkers in precision medicine: Precision medicine is an approach to healthcare that takes into account the individual characteristics of each patient to develop the most effective treatment plan. Veterinary biomarkers are being used to develop precision medicine approaches for a variety of animal diseases.
Global veterinary biomarkers industry segmentation
The global veterinary biomarkers market is segmented as Biomarker Type (Protein Biomarkers, Genetic Biomarkers, Metabolomics Biomarkers, Hormonal Biomarkers, and Other Biomarker Types), Species (Companion Animals (Dogs, Cats, Horses), Livestock Animals (Cattle, Poultry, Pigs, Sheep), and Wildlife Animals), Application (Disease Diagnostics, Drug Development, Predictive Medicine, Research and Development), End User (Veterinary Clinics and Hospitals, Veterinary Research Institutions, Pharmaceutical and Biotechnology Companies, Livestock and Production Facilities , and Conservation Organizations)
Based on biomarker type, the protein biomarkers segment is expected to grow at the high rate during the forecast period. In 2022, the segment contributed around 20.1% of the overall market. Protein biomarkers tend to lead among biomarker types due to their established role in reflecting diverse animal health conditions, ease of detection, and widespread use in disease diagnosis, prognosis, and treatment monitoring.
Based on species, in 2022, the companion animals segment is expected to hold large share of 40.1% in the market. Companion animals, such as dogs, cats, and horses, tend to lead in the application of veterinary biomarkers due to the strong human-animal bond and personalized care they receive. Nevertheless, biomarkers are gaining importance in livestock animals and wildlife management as well, driven by concerns about food safety, animal welfare, and conservation.
Based on application, the disease diagnostics segment is expected to grow with the CAGR of 11.5% during the forecast period. Disease diagnostics typically leads among applications of veterinary biomarkers. The primary role of biomarkers in veterinary medicine is to aid in identifying and diagnosing various diseases in animals. Biomarkers provide valuable insights into the presence of diseases, their stages, and potential complications. While biomarkers also play important roles in drug development, predictive medicine, and research, disease diagnostics remains a prominent and foundational application in the veterinary biomarker field.
Based on end user, the veterinary clinics and hospitals segment is expected to grow with the CAGR of 9.3% during the forecast period. Veterinary clinics and hospitals are the primary leaders among end users in the application of veterinary biomarkers, due to their direct clinical impact on disease diagnosis and treatment monitoring for individual animals. Other sectors, including research institutions, pharmaceutical companies, livestock facilities, and conservation organizations, also use biomarkers for specific purposes, but clinical settings have a more significant influence on biomarker utilization.
Global veterinary biomarkers industry competitors
Key players operating in the global veterinary biomarkers market include Merck & Co., Inc., Zoetis Inc., IDEXX Laboratories, Heska Corporation, Randox Laboratories Ltd., Neogen Corporation, Thermo Fisher Scientific, Idexx BioAnalytics, QIAGEN N.V., and Bio-Rad Laboratories.
Industry Developments:
In 2022, Bionote USA launched Vcheck biomarkers for the diagnosis of heart failure in dogs. This test can be used in-clinic to quickly and accurately diagnose canine heart disease, which can help to improve the quality of life and prognosis for affected dogs.
In 2022, Life Science Diagnostics developed three monoclonal antibodies for SAA, an acute-phase protein that is an excellent biomarker for inflammation and tissue injury. These antibodies can be used to develop ELISA kits for the detection of SAA in animals, which can be used to diagnose and monitor a variety of inflammatory and infectious diseases.
In 2022, Idexx Laboratories launched a new point-of-care test for the detection of canine heartworm disease. This test can be used in veterinary clinics to quickly and easily diagnose heartworm disease, which is a serious and potentially fatal condition in dogs.
Major Strategies adopted by key market players
- Agreements, Collaborations, and Partnerships: 34.9%
- Acquisitions: 24%
- New Product Launch: 22%
- Other Developments: 19.1%
Scope of the Report:
Global Veterinary Biomarkers Market, by Biomarker Type
- Protein biomarkers
- Genetic biomarkers
- Metabolomics biomarkers
- Hormonal biomarkers
- Other Biomarker Types
Global Veterinary Biomarkers Market, By Species:
- Companion animals (dogs, cats, horses, etc.)
- Livestock animals (cattle, poultry, pigs, sheep, etc.)
- Wildlife Animals
Global Veterinary Biomarkers Market, By Application:
- Disease Diagnostics
- Drug Development
- Predictive Medicine
- Research and Development.
Global Veterinary Biomarkers Market, By End user:
- Veterinary Clinics and Hospitals
- Veterinary Research Institutions
- Pharmaceutical and Biotechnology Companies
- Livestock and Production Facilities
- Conservation Organizations
Global Veterinary Biomarkers Market, By Region
- North America
- Europe
- Germany
- U.K
- France
- Italy
- Spain
- Rest of Europe (RoE)
- Asia-Pacific (APAC)
- China
- Japan
- India
- Rest of APAC (RoAPAC)
- South America
-
- Brazil
- Argentina
- Rest of South America
-
- GCC
- Israel
- South Africa
- Rest of MEA
Companies Profiled
- Merck & Co., Inc.
- Zoetis Inc.
- IDEXX Laboratories
- Heska Corporation
- Randox Laboratories Ltd.
- Neogen Corporation
- Thermo Fisher Scientific
- Idexx BioAnalytics
- QIAGEN N.V.
- Bio-Rad Laboratories
*The report scope shall be customized as per the requirements
Chapter 1 Global Veterinary Biomarkers Market Overview
1.1 Introduction
1.2 Drivers for Veterinary Biomarkers Market
1.3 Restraints for Veterinary Biomarkers Market
1.4 Opportunities for Veterinary Biomarkers Market
1.5 Trends for Veterinary Biomarkers Market
1.6 Macro-economic Factors
1.7 Regulatory Framework
1.8 Opportunity Map Analysis
1.9 Opportunity Orbits
1.10 Market Investment Feasibility Index
1.11 PEST Analysis
1.12 PORTER’S Five Force Analysis
1.13 Go to Market Strategy
1.14 Marketing Strategy
1.15 Technology Roadmap
1.16 Advances in product/services adoption worldwide
1.17 Regional Market Share and BPS Analysis
Chapter 2 Global Veterinary Biomarkers Market Competitive Analysis
2.1 Market Competition Scenario Analysis, By Company
2.2 Competitor Landscape
2.3 Major Strategies adopted by key market players (2020-2022)
2.4 Recent Developments/Investments/Announcements
2.5 Company Profiles
2.5.1 Merck & Co., Inc.
2.5.1.1 Company Overview
2.5.1.2 Business Description
2.5.1.3 Product Portfolio
2.5.1.4 Key Financials
2.5.1.5 Company Presence & Business Segment Analysis – 2022
2.5.1.6 Key Developments
2.5.1.7 SWOT Analysis
2.5.2 Zoetis Inc.
2.5.2.1 Company Overview
2.5.2.2 Business Description
2.5.2.3 Product Portfolio
2.5.2.4 Key Financials
2.5.2.5 Company Presence & Business Segment Analysis – 2022
2.5.2.6 Key Developments
2.5.2.7 SWOT Analysis
2.5.3 IDEXX Laboratories
2.5.3.1 Company Overview
2.5.3.2 Business Description
2.5.3.3 Product Portfolio
2.5.3.4 Key Financials
2.5.3.5 Company Presence & Business Segment Analysis – 2022
2.5.3.6 Key Developments
2.5.3.7 SWOT Analysis
2.5.4 Heska Corporation
2.5.4.1 Company Overview
2.5.4.2 Business Description
2.5.4.3 Product Portfolio
2.5.4.4 Key Financials
2.5.4.5 Company Presence & Business Segment Analysis – 2022
2.5.4.6 Key Developments
2.5.4.7 SWOT Analysis
2.5.5 Randox Laboratories Ltd.
2.5.5.1 Company Overview
2.5.5.2 Business Description
2.5.5.3 Product Portfolio
2.5.5.4 Key Financials
2.5.5.5 Company Presence & Business Segment Analysis – 2022
2.5.5.6 Key Developments
2.5.5.7 SWOT Analysis
2.5.6 Neogen Corporation
2.5.6.1 Company Overview
2.5.6.2 Business Description
2.5.6.3 Product Portfolio
2.5.6.4 Key Financials
2.5.6.5 Company Presence & Business Segment Analysis – 2022
2.5.6.6 Key Developments
2.5.6.7 SWOT Analysis
2.5.7 Thermo Fisher Scientific
2.5.7.1 Company Overview
2.5.7.2 Business Description
2.5.7.3 Product Portfolio
2.5.7.4 Key Financials
2.5.7.5 Company Presence & Business Segment Analysis – 2022
2.5.7.6 Key Developments
2.5.7.7 SWOT Analysis
2.5.8 Idexx BioAnalytics
2.5.8.1 Company Overview
2.5.8.2 Business Description
2.5.8.3 Product Portfolio
2.5.8.4 Key Financials
2.5.8.5 Company Presence & Business Segment Analysis – 2022
2.5.8.6 Key Developments
2.5.8.7 SWOT Analysis
2.5.9 QIAGEN N.V.
2.5.9.1 Company Overview
2.5.9.2 Business Description
2.5.9.3 Product Portfolio
2.5.9.4 Key Financials
2.5.9.5 Company Presence & Business Segment Analysis – 2022
2.5.9.6 Key Developments
2.5.9.7 SWOT Analysis
2.5.10 Bio-Rad Laboratories
2.5.10.1 Company Overview
2.5.10.2 Business Description
2.5.10.3 Product Portfolio
2.5.10.4 Key Financials
2.5.10.5 Company Presence & Business Segment Analysis – 2022
2.5.10.6 Key Developments
2.5.10.7 SWOT Analysis
Chapter 3 Global Veterinary Biomarkers Market Overview
3.1 Global Veterinary Biomarkers Market Outlook (2017-2032)
3.1.1 Global Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) (2017-2023)
3.1.2 Global Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) (2024-2032)
3.2 Global Veterinary Biomarkers Market by Region
3.2.1 Global Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
3.2.2 Global Veterinary Biomarkers Market Attractiveness Analysis by Region, 2023–2032
3.3 Global Veterinary Biomarkers Market by Biomarker Type
3.3.1 Global Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) Comparison by Biomarker Type (2017-2032)
3.3.2 Global Veterinary Biomarkers Market Attractiveness Analysis by Biomarker Type, 2023–2032
3.3.3 Global Veterinary Biomarkers Market Attractiveness Analysis by Region, 2023–2032
3.4 Global Veterinary Biomarkers Market by Species
3.4.1 Global Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) Comparison by Species (2017-2032)
3.4.2 Global Veterinary Biomarkers Market Attractiveness Analysis by Species, 2023–2032
3.5 Global Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) by Region
3.5.1 Global Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
3.5.2 Global Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
3.6 Global Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) by Biomarker Type
3.6.1 Global Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) Comparison by Biomarker Type (2017-2023)
3.6.2 Global Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) Comparison by Biomarker Type (2024-2032)
3.7 Global Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) by Species
3.7.1 Global Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) Comparison by Species (2017-2023)
3.7.2 Global Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) Comparison by Species (2024-2032)
3.8 Global Veterinary Biomarkers Market Y-o-Y Growth Rate Comparison 2018–2032
3.8.1 Global Veterinary Biomarkers Market Y-o-Y Growth Rate by Region
3.8.2 Global Veterinary Biomarkers Market Y-o-Y Growth Rate by Biomarker Type
3.8.3 Global Veterinary Biomarkers Market Y-o-Y Growth Rate by Species
3.9 Global Veterinary Biomarkers Market Share Comparison 2017–2032
3.9.1 Global Veterinary Biomarkers Market Share by Region
3.9.2 Global Veterinary Biomarkers Market Share by Biomarker Type
3.9.3 Global Veterinary Biomarkers Market Share by Species
Chapter 4 North America Veterinary Biomarkers Market Overview
4.1 North America Market Snapshot
4.1.1 Regional Overview
4.1.1.1 US
4.1.1.2 Canada
4.1.1.3 Mexico
4.2 North America Veterinary Biomarkers Market Outlook (2017-2032)
4.2.1 North America Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) (2017-2023)
4.2.2 North America Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) (2024-2032)
4.3 North America Veterinary Biomarkers Market by Region
4.3.1 North America Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
4.3.2 North America Veterinary Biomarkers Market Attractiveness Analysis by Region, 2023–2032
4.4 North America Veterinary Biomarkers Market by Biomarker Type
4.4.1 North America Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) Comparison by Biomarker Type (2017-2032)
4.4.2 North America Veterinary Biomarkers Market Attractiveness Analysis by Biomarker Type, 2023–2032
4.4.3 North America Veterinary Biomarkers Market Attractiveness Analysis by Region, 2023–2032
4.5 North America Veterinary Biomarkers Market by Species
4.5.1 North America Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) Comparison by Species (2017-2032)
4.5.2 North America Veterinary Biomarkers Market Attractiveness Analysis by Species, 2023–2032
4.6 North America Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) by Region
4.6.1 North America Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
4.6.2 North America Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
4.7 North America Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) by Biomarker Type
4.7.1 North America Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) Comparison by Biomarker Type (2017-2023)
4.7.2 North America Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) Comparison by Biomarker Type (2024-2032)
4.8 North America Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) by Species
4.8.1 North America Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) Comparison by Species (2017-2023)
4.8.2 North America Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) Comparison by Species (2024-2032)
4.9 North America Veterinary Biomarkers Market Y-o-Y Growth Rate Comparison 2018–2032
4.9.1 North America Veterinary Biomarkers Market Y-o-Y Growth Rate by Region
4.9.2 North America Veterinary Biomarkers Market Y-o-Y Growth Rate by Biomarker Type
4.9.3 North America Veterinary Biomarkers Market Y-o-Y Growth Rate by Species
4.1 North America Veterinary Biomarkers Market Share Comparison 2017–2032
4.10.1 North America Veterinary Biomarkers Market Share by Region
4.10.2 North America Veterinary Biomarkers Market Share by Biomarker Type
4.10.3 North America Veterinary Biomarkers Market Share by Species
Chapter 5 Europe Veterinary Biomarkers Market Overview
5.1 Europe Market Snapshot
5.1.1 Regional Overview
5.1.1.1 Germany
5.1.1.2 United Kingdom
5.1.1.3 France
5.1.1.4 Italy
5.1.1.5 Spain
5.1.1.6 Russia
5.1.1.7 Rest of Europe
5.2 Europe Veterinary Biomarkers Market Outlook (2017-2032)
5.2.1 Europe Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) (2017-2023)
5.2.2 Europe Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) (2024-2032)
5.3 Europe Veterinary Biomarkers Market by Region
5.3.1 Europe Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
5.3.2 Europe Veterinary Biomarkers Market Attractiveness Analysis by Region, 2023–2032
5.4 Europe Veterinary Biomarkers Market by Biomarker Type
5.4.1 Europe Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) Comparison by Biomarker Type (2017-2032)
5.4.2 Europe Veterinary Biomarkers Market Attractiveness Analysis by Biomarker Type, 2023–2032
5.4.3 Europe Veterinary Biomarkers Market Attractiveness Analysis by Region, 2023–2032
5.5 Europe Veterinary Biomarkers Market by Species
5.5.1 Europe Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) Comparison by Species (2017-2032)
5.5.2 Europe Veterinary Biomarkers Market Attractiveness Analysis by Species, 2023–2032
5.6 Europe Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) by Region
5.6.1 Europe Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
5.6.2 Europe Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
5.7 Europe Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) by Biomarker Type
5.7.1 Europe Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) Comparison by Biomarker Type (2017-2023)
5.7.2 Europe Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) Comparison by Biomarker Type (2024-2032)
5.8 Europe Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) by Species
5.8.1 Europe Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) Comparison by Species (2017-2023)
5.8.2 Europe Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) Comparison by Species (2024-2032)
5.9 Europe Veterinary Biomarkers Market Y-o-Y Growth Rate Comparison 2018–2032
5.9.1 Europe Veterinary Biomarkers Market Y-o-Y Growth Rate by Region
5.9.2 Europe Veterinary Biomarkers Market Y-o-Y Growth Rate by Biomarker Type
5.9.3 Europe Veterinary Biomarkers Market Y-o-Y Growth Rate by Species
5.1 Europe Veterinary Biomarkers Market Share Comparison 2017–2032
5.10.1 Europe Veterinary Biomarkers Market Share by Region
5.10.2 Europe Veterinary Biomarkers Market Share by Biomarker Type
5.10.3 Europe Veterinary Biomarkers Market Share by Species
Chapter 6 Asia Pacific Veterinary Biomarkers Market Overview
6.1 Asia Pacific Market Snapshot
6.1.1 Regional Overview
6.1.1.1 China
6.1.1.2 India
6.1.1.3 Japan
6.1.1.4 Australia
6.1.1.5 Rest of Asia Pacific
6.2 Asia Pacific Veterinary Biomarkers Market Outlook (2017-2032)
6.2.1 Asia Pacific Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) (2017-2023)
6.2.2 Asia Pacific Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) (2024-2032)
6.3 Asia Pacific Veterinary Biomarkers Market by Region
6.3.1 Asia Pacific Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
6.3.2 Asia Pacific Veterinary Biomarkers Market Attractiveness Analysis by Region, 2023–2032
6.4 Asia Pacific Veterinary Biomarkers Market by Biomarker Type
6.4.1 Asia Pacific Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) Comparison by Biomarker Type (2017-2032)
6.4.2 Asia Pacific Veterinary Biomarkers Market Attractiveness Analysis by Biomarker Type, 2023–2032
6.4.3 Asia Pacific Veterinary Biomarkers Market Attractiveness Analysis by Region, 2023–2032
6.5 Asia Pacific Veterinary Biomarkers Market by Species
6.5.1 Asia Pacific Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) Comparison by Species (2017-2032)
6.5.2 Asia Pacific Veterinary Biomarkers Market Attractiveness Analysis by Species, 2023–2032
6.6 Asia Pacific Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) by Region
6.6.1 Asia Pacific Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
6.6.2 Asia Pacific Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
6.7 Asia Pacific Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) by Biomarker Type
6.7.1 Asia Pacific Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) Comparison by Biomarker Type (2017-2023)
6.7.2 Asia Pacific Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) Comparison by Biomarker Type (2024-2032)
6.8 Asia Pacific Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) by Species
6.8.1 Asia Pacific Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) Comparison by Species (2017-2023)
6.8.2 Asia Pacific Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) Comparison by Species (2024-2032)
6.9 Asia Pacific Veterinary Biomarkers Market Y-o-Y Growth Rate Comparison 2018–2032
6.9.1 Asia Pacific Veterinary Biomarkers Market Y-o-Y Growth Rate by Region
6.9.2 Asia Pacific Veterinary Biomarkers Market Y-o-Y Growth Rate by Biomarker Type
6.9.3 Asia Pacific Veterinary Biomarkers Market Y-o-Y Growth Rate by Species
6.1 Asia Pacific Veterinary Biomarkers Market Share Comparison 2017–2032
6.10.1 Asia Pacific Veterinary Biomarkers Market Share by Region
6.10.2 Asia Pacific Veterinary Biomarkers Market Share by Biomarker Type
6.10.3 Asia Pacific Veterinary Biomarkers Market Share by Species
Chapter 7 South America Veterinary Biomarkers Market Overview
7.1 South America Market Snapshot
7.1.1 Regional Overview
7.1.1.1 Brazil
7.1.1.2 Argentina
7.1.1.3 Rest of South America
7.2 South America Veterinary Biomarkers Market Outlook (2017-2032)
7.2.1 South America Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) (2017-2023)
7.2.2 South America Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) (2024-2032)
7.3 South America Veterinary Biomarkers Market by Region
7.3.1 South America Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
7.3.2 South America Veterinary Biomarkers Market Attractiveness Analysis by Region, 2023–2032
7.4 South America Veterinary Biomarkers Market by Biomarker Type
7.4.1 South America Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) Comparison by Biomarker Type (2017-2032)
7.4.2 South America Veterinary Biomarkers Market Attractiveness Analysis by Biomarker Type, 2023–2032
7.4.3 South America Veterinary Biomarkers Market Attractiveness Analysis by Region, 2023–2032
7.5 South America Veterinary Biomarkers Market by Species
7.5.1 South America Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) Comparison by Species (2017-2032)
7.5.2 South America Veterinary Biomarkers Market Attractiveness Analysis by Species, 2023–2032
7.6 South America Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) by Region
7.6.1 South America Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
7.6.2 South America Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
7.7 South America Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) by Biomarker Type
7.7.1 South America Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) Comparison by Biomarker Type (2017-2023)
7.7.2 South America Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) Comparison by Biomarker Type (2024-2032)
7.8 South America Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) by Species
7.8.1 South America Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) Comparison by Species (2017-2023)
7.8.2 South America Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) Comparison by Species (2024-2032)
7.9 South America Veterinary Biomarkers Market Y-o-Y Growth Rate Comparison 2018–2032
7.9.1 South America Veterinary Biomarkers Market Y-o-Y Growth Rate by Region
7.9.2 South America Veterinary Biomarkers Market Y-o-Y Growth Rate by Biomarker Type
7.9.3 South America Veterinary Biomarkers Market Y-o-Y Growth Rate by Species
7.1 South America Veterinary Biomarkers Market Share Comparison 2017–2032
7.10.1 South America Veterinary Biomarkers Market Share by Region
7.10.2 South America Veterinary Biomarkers Market Share by Biomarker Type
7.10.3 South America Veterinary Biomarkers Market Share by Species
Chapter 8 Middle East and Africa Veterinary Biomarkers Market Overview
8.1 Middle East and Africa Market Snapshot
8.1.1 Regional Overview
8.1.1.1 GCC
8.1.1.2 South Africa
8.1.1.3 Israel
8.1.1.4 Rest of Middle East and Africa
8.2 Middle East and Africa Veterinary Biomarkers Market Outlook (2017-2032)
8.2.1 Middle East and Africa Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) (2017-2023)
8.2.2 Middle East and Africa Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) (2024-2032)
8.3 Middle East and Africa Veterinary Biomarkers Market by Region
8.3.1 Middle East and Africa Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
8.3.2 Middle East and Africa Veterinary Biomarkers Market Attractiveness Analysis by Region, 2023–2032
8.4 Middle East and Africa Veterinary Biomarkers Market by Biomarker Type
8.4.1 Middle East and Africa Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) Comparison by Biomarker Type (2017-2032)
8.4.2 Middle East and Africa Veterinary Biomarkers Market Attractiveness Analysis by Biomarker Type, 2023–2032
8.4.3 Middle East and Africa Veterinary Biomarkers Market Attractiveness Analysis by Region, 2023–2032
8.5 Middle East and Africa Veterinary Biomarkers Market by Species
8.5.1 Middle East and Africa Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) Comparison by Species (2017-2032)
8.5.2 Middle East and Africa Veterinary Biomarkers Market Attractiveness Analysis by Species, 2023–2032
8.6 Middle East and Africa Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) by Region
8.6.1 Middle East and Africa Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
8.6.2 Middle East and Africa Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
8.7 Middle East and Africa Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) by Biomarker Type
8.7.1 Middle East and Africa Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) Comparison by Biomarker Type (2017-2023)
8.7.2 Middle East and Africa Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) Comparison by Biomarker Type (2024-2032)
8.8 Middle East and Africa Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) by Species
8.8.1 Middle East and Africa Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) Comparison by Species (2017-2023)
8.8.2 Middle East and Africa Veterinary Biomarkers Market Value (US$ Mn) and Volume (Units) Comparison by Species (2024-2032)
8.9 Middle East and Africa Veterinary Biomarkers Market Y-o-Y Growth Rate Comparison 2018–2032
8.9.1 Middle East and Africa Veterinary Biomarkers Market Y-o-Y Growth Rate by Region
8.9.2 Middle East and Africa Veterinary Biomarkers Market Y-o-Y Growth Rate by Biomarker Type
8.9.3 Middle East and Africa Veterinary Biomarkers Market Y-o-Y Growth Rate by Species
8.1 Middle East and Africa Veterinary Biomarkers Market Share Comparison 2017–2032
8.10.1 Middle East and Africa Veterinary Biomarkers Market Share by Region
8.10.2 Middle East and Africa Veterinary Biomarkers Market Share by Biomarker Type
8.10.3 Middle East and Africa Veterinary Biomarkers Market Share by Species
Chapter 9 Methodology and Data Source
9.1 Research Approach/ Methodology
9.2 Market Size Estimation
9.3 Market Breakdown and Data Triangulation
9.4 Data Source
9.4.1 Secondary Sources
9.4.2 Primary Sources
